AlphaGrep UK’s Madison Square Garden MSGS Stock Holding History

AlphaGrep UK’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,561	Closed	-$502K	–	878
2026 Q1	$502K	Buy	1,561 +387	+33%	+$115K	0.15%	244
2025 Q4	$304K	Buy	+1,174	New	+$267K	0.1%	424

Other funds holding MSGS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Starlite Capital Dallas, Texas $9.7B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACP

Avantyr Capital Partners New York $2.72B AUM

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

AlphaGrep UK's MSGS Position: Q2 2026 in Review

AlphaGrep UK sold out of Madison Square Garden (MSGS) in Q2 2026, closing a stake of 1,561 shares — an estimated $502K sold.

AlphaGrep UK first reported a position in MSGS in Q4 2025 and held it in 2 quarters. The position peaked at $502K in Q1 2026. 438 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

AlphaGrep UK reported no remaining Madison Square Garden position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 1,561 Madison Square Garden shares in Q2 2026, an estimated $502K.
AlphaGrep UK first reported a position in Madison Square Garden in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Madison Square Garden position peaked at $502K in Q1 2026.
438 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.